Skip to main content

Peer Review reports

From: Bortezomib and dexamethasone for multiple myeloma: higher AST and LDH levels associated with a worse prognosis on overall survival

Original Submission
26 Feb 2014 Submitted Original manuscript
3 Apr 2014 Reviewed Reviewer Report - George Tsirakis
13 Apr 2014 Reviewed Reviewer Report - Eleni Mayson
8 May 2014 Author responded Author comments - Takayoshi Kiba
Resubmission - Version 2
8 May 2014 Submitted Manuscript version 2
6 Jun 2014 Author responded Author comments - Takayoshi Kiba
Resubmission - Version 3
6 Jun 2014 Submitted Manuscript version 3
10 Jun 2014 Author responded Author comments - Takayoshi Kiba
Resubmission - Version 4
10 Jun 2014 Submitted Manuscript version 4
11 Jun 2014 Author responded Author comments - Takayoshi Kiba
Resubmission - Version 5
11 Jun 2014 Submitted Manuscript version 5
Publishing
18 Jun 2014 Editorially accepted
21 Jun 2014 Article published 10.1186/1471-2407-14-462

You can find further information about peer review here.

Back to article page